Media Coverage header image

Media Coverage

Advanced Search
  • 10142024
    Becker's Hospital Review

    Quest Diagnostics has completed its purchase of select laboratory assets from Columbus-based OhioHealth. The two parties signed an agreement for the assets in early July, with financial terms from the transaction not shared. The purchase aims to expand access to cost-effective laboratory services in Ohio.

  • 10022024
    Modern Healthcare

    Quest Diagnostics has announced seven acquisitions this year, including its recent purchase of select lab assets from Minneapolis-based Allina Health. Slated to close later this year are deals with OhioHealth in Columbus and University Hospitals in Cleveland. "In order to grow our business, we want to be able to do more work with hospitals that are doing outpatient or outreach lab tests ordered by independent physicians outside of their facility,” said Jim Davis, president and CEO of Quest Diagnostics.

  • 09232024
    Woman's World

    Type 2 diabetes is a chronic condition where the body either doesn’t produce enough insulin or doesn’t use it effectively, causing high blood sugar levels. Insulin is crucial for helping the body convert glucose into energy. When insulin doesn’t work properly, glucose accumulates in the bloodstream, leading to increased blood sugar. Over time, this can result in serious complications such as organ damage and a higher risk of heart attack or stroke. “Diabetes can affect every organ system,” says Sanjay Dixit, MD, medical director of cardiometabolic endocrine and wellness clinical solutions at Quest Diagnostics. “Early detection and management of type 2 diabetes is crucial.”

  • 09172024
    Modern Healthcare

    Quest Diagnostics on Monday completed its acquisition of select lab assets of Allina Health in a deal that builds on the industry trend of independent companies taking over the outpatient lab operations of health systems.

  • 09132024
    360Dx

    Quest Diagnostics and Sentara Health Plans said Wednesday that they have entered into a multi-year strategic collaboration. Under the agreement, Quest will, at the beginning of 2025, become the exclusive independent national laboratory provider of clinical laboratory and anatomic pathology services for Sentara members in Florida and Virginia.

Show 5102550100 per page